Financing ·
Jaguar Health reduces $6.2M secured promissory note by $3.4M via issuance of 481,584 shares to Streeterville Capital
JAGXJaguar Health, Inc.
On September 25, 2026, Jaguar Health, Inc. entered into exchange agreements with Streeterville Capital, LLC to reduce the outstanding balance of its $6,220,812.50 secured promissory note by $3,400,000. In consideration for this debt reduction, the Company issued 481,584 shares of common stock to Streeterville. Following this transaction, the total number of shares outstanding was approximately 1,945,542. Jaguar Health, Inc. operates in the pharmaceutical industry, developing and commercializing treatments for gastrointestinal disorders.